These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16281480)

  • 1. [Treatment of ischemic heart disease: old traditions and new trends].
    Belenkov IuN
    Ter Arkh; 2005; 77(9):5-8. PubMed ID: 16281480
    [No Abstract]   [Full Text] [Related]  

  • 2. [The ischemic heart--causes, effects and therapy].
    Tillmanns H
    Klin Anasthesiol Intensivther; 1995; 47():206-20. PubMed ID: 7715175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of pharmacotherapy and it's effectiveness in ischemic heart disease and arterial hypertension, conducted by doctors in specialist and regional outpatient clinics].
    Guzecka-Ruszczyńska E; Czarnecki A
    Wiad Lek; 1994 May; 47(9-10):352-7. PubMed ID: 7817593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent ischaemia: to treat or not to treat?
    Deedwania PC
    Indian Heart J; 1996; 48(4):415-9. PubMed ID: 8908836
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of different methods of photohemotherapy on the rheological properties of the blood in patients with ischemic heart disease].
    Gavrisheva IA; Dutkevich IG; Pleshakov VT; Kolesnik VS
    Vestn Khir Im I I Grek; 2000; 159(2):60-4. PubMed ID: 10890073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Means for increasing treatment efficacy in patients with ischemic heart disease].
    Chazov EI
    Ter Arkh; 1997; 69(9):5-10. PubMed ID: 9411827
    [No Abstract]   [Full Text] [Related]  

  • 7. [The therapeutic prospects of ischemic cardiopathy].
    Rossi F; Matera MG; Filippelli A; Giasi M; Fici F
    Clin Ter; 1994 Apr; 144(4):333-53. PubMed ID: 8205757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in ischaemic heart disease].
    Alegria E; Velasco A; Azcárate P
    Rev Med Univ Navarra; 2005; 49(3):16-30. PubMed ID: 16400973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of ischemic heart disease in patients with chronic kidney failure].
    Diadyk AI; Bagriĭ AE; Stulikova EL
    Lik Sprava; 1998 Jun; (4):42-5. PubMed ID: 9784699
    [No Abstract]   [Full Text] [Related]  

  • 10. [The current aspects of the pharmacological protection of the ischemic myocardium].
    Chichkanov GG
    Eksp Klin Farmakol; 1994; 57(6):15-20. PubMed ID: 7756948
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of perhexiline in ischaemic heart failure.
    Noble MI; Drake-Holland AJ
    Int J Cardiol; 2010 Mar; 139(2):105-6. PubMed ID: 19748138
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy with stem cells for acute ischemic heart disease: myocardial regeneration?].
    Ripa RS; Wang Y; Jørgensen E; Kastrup J
    Ugeskr Laeger; 2007 Jan; 169(2):119-22. PubMed ID: 17227657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of cardiovascular agents on the hemostatic system in myocardial ischemia].
    Denisova SV; Sapozhkov AV
    Eksp Klin Farmakol; 1995; 58(4):63-8. PubMed ID: 7580758
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indices of lipid peroxidation and atherogenic blood lipoproteins in patients with coronary heart disease receiving antioxidants in addition to basic therapy].
    Reĭzin AB; Tel'nykh IuV
    Klin Med (Mosk); 2005; 83(11):63-4. PubMed ID: 16404943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients.
    Ranchord AM; Harding SA; Pidgeon G
    Intern Med J; 2008 May; 38(5):361-4. PubMed ID: 18402563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological approaches to ischemic tissue repair: gene- and cell-based strategies.
    Roncalli J; Tongers J; Renault MA; Losordo DW
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):653-68. PubMed ID: 18510483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ion channel therapy of ischemic heart disease].
    Conti CR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):254-5. PubMed ID: 22801274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spa and resort treatment of patients with ischemic heart disease including magnetopeloido therapy and sulfurated hydrogen baths].
    Konovalova MP; Utekhina VP; Khodasevich LS
    Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (4):3-4. PubMed ID: 18822479
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.
    Kapur V; Chien CV; Fuess JE; Schwarz ER
    Rev Cardiovasc Med; 2008; 9(3):187-95. PubMed ID: 18953278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.